Vallance P - Search Results

1

Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease.

Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, Vallance P, Humphries SE, Hingorani AD. Jeerooburkhan N, et al. Among authors: vallance p. Hypertension. 2001 Nov;38(5):1054-61. doi: 10.1161/hy1101.092967. Hypertension. 2001. PMID: 11711497

2

Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy.

Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD. Savvidou MD, et al. Among authors: vallance pj. Hypertension. 2001 Dec 1;38(6):1289-93. doi: 10.1161/hy1201.097305. Hypertension. 2001. PMID: 11751705 Clinical Trial.

3

Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study.

Serrano NC, Casas JP, Díaz LA, Páez C, Mesa CM, Cifuentes R, Monterrosa A, Bautista A, Hawe E, Hingorani AD, Vallance P, López-Jaramillo P. Serrano NC, et al. Among authors: vallance p. Hypertension. 2004 Nov;44(5):702-7. doi: 10.1161/01.HYP.0000143483.66701.ec. Epub 2004 Sep 13. Hypertension. 2004. PMID: 15364897

4

A simple computer program for guiding management of cardiovascular risk factors and prescribing.

Hingorani AD, Vallance P. Hingorani AD, et al. Among authors: vallance p. BMJ. 1999 Jan 9;318(7176):101-5. doi: 10.1136/bmj.318.7176.101. BMJ. 1999. PMID: 9880285 Free PMC article.

5

Endothelial nitric oxide in humans in health and disease.

Vallance P, Hingorani A. Vallance P, et al. Int J Exp Pathol. 1999 Dec;80(6):291-303. doi: 10.1046/j.1365-2613.1999.00137.x. Int J Exp Pathol. 1999. PMID: 10632779 Free PMC article. Review. No abstract available.

6

Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells.

Jones LC, Tran CT, Leiper JM, Hingorani AD, Vallance P. Jones LC, et al. Among authors: vallance p. Biochem Biophys Res Commun. 2003 Oct 24;310(3):836-43. doi: 10.1016/j.bbrc.2003.09.097. Biochem Biophys Res Commun. 2003. PMID: 14550280

7

Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS.

Bhagat K, Hingorani AD, Palacios M, Charles IG, Vallance P. Bhagat K, et al. Among authors: vallance p. Cardiovasc Res. 1999 Mar;41(3):754-64. doi: 10.1016/s0008-6363(98)00249-1. Cardiovasc Res. 1999. PMID: 10435048

8

What is the optimal age for starting lipid lowering treatment? A mathematical model.

Ulrich S, Hingorani AD, Martin J, Vallance P. Ulrich S, et al. Among authors: vallance p. BMJ. 2000 Apr 22;320(7242):1134-40. doi: 10.1136/bmj.320.7242.1134. BMJ. 2000. PMID: 10775228 Free PMC article. Review. No abstract available.

9

Changes in endothelium-dependent vasodilatation and alpha-adrenergic responses in resistance vessels during the menstrual cycle in healthy women.

Chan NN, MacAllister RJ, Colhoun HM, Vallance P, Hingorani AD. Chan NN, et al. Among authors: vallance p. J Clin Endocrinol Metab. 2001 Jun;86(6):2499-504. doi: 10.1210/jcem.86.6.7581. J Clin Endocrinol Metab. 2001. PMID: 11397846

10

Lifetime risk of developing coronary heart disease.

Ulrich S, Hingorani AD, Martin J, Vallance P. Ulrich S, et al. Among authors: vallance p. Lancet. 1999 Mar 13;353(9156):925. doi: 10.1016/S0140-6736(05)75030-3. Lancet. 1999. PMID: 10094006 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters